CYBB and cardiomyopathy: NOX2, expressed in the heart, not only mediates oxidative stress, apoptosis, and inflammation through multiple target pathway proteins but is also subject to gene-level regulators, such as microRNAs (miRNAs) for its downstream products, to reduce its activity and slow the progression of cardiomyopathy and myocardial remodeling after MI (94).